Aerospace and defense (A&D) executives know how to make the industry an attractive employer again. (Photo generated using DALL·E) This article is contributed by Stephane Lagut, EY Global Aerospace and Defense Leader. Across the world, our working habits have changed dramatically in the last few years. Very few industries have escaped this shift, and aerospace is no different. While still dealing with the effects of a massive dip in revenue, leading to large job losses across the industry, aerospace (along with other industries) is now facing what some are calling the Great Disengagement as it struggles to hire, retain and motivate its workforce. In the last 12 months, many executives in the industry have noticed a sharp drop in employee engagement, a steep rise in turnover, and a frightening lack of response to the instruments they usually use to keep their factories and workshops staffed. In a recent survey by the Aerospace Industries Association, the American Institute of Aeronautics and Astronautics and EY, 41% of A&D executives told researchers they thought employees had become less engaged in the last 12 months and 69% said turnover had increased. Overall turnover rose dramatically in 2022, to 7.1%, up from 5.8% in […]

Click here to view original web page at www.aviationtoday.com

Delaware companies that are in the beginning stages and need funding to help expand their business can now apply to compete for an Encouraging Development, Growth and Expansion (EDGE) grant from the Division of Small Business (DSB). The division will be accepting EDGE grant applications between now and March 31 from promising early-stage businesses throughout Delaware. Businesses that are less than seven years old and employ no more than 10 employees are eligible to apply for an EDGE grant. In previous rounds, businesses were required to be less than five years old, but DSB chose to expand this requirement to provide more small businesses with the opportunity to apply for funding. Businesses should visit the Division of Small Business website for eligibility requirements, to download the grant application and to connect with a Regional Business Manager for application assistance.

Click here to view original web page at www.wgmd.com

Tyler Pasciak LaRiviere/Sun-Times file BMO Tower, 320 S. Canal St., was completed in 2022. Yankees? Celtics? Jordan-era Bulls? Step aside, all. For the 10th straight year, the Chicago area is No. 1, not in a mere sport, but in the standings of Site Selection magazine. Among large metro areas in the U.S., the Chicago region in 2022 again recorded the most business relocations and expansions, the publication said. The honors from Site Selection have for years given civic boosters a rejoinder against critics who argue that crime and taxes are combining to push companies out of the region and state. Many point to the departures of big employers such as Caterpillar and Citadel as examples. Boeing also is frequently cited, although its headquarters move from Chicago involved few jobs being shifted. “I guess data can belie the perception,” said Adam Bruns, the magazine’s managing editor. “High-profile departures can sometimes overshadow the arrivals.” He said Cook and its nearby counties are reaping the benefits of location in the center of the country and access to a deep labor pool. Bruns also said Chicago has enjoyed “good sustainable momentum in a number of economic sectors,” including technology, life sciences and data […]

Click here to view original web page at chicago.suntimes.com

King brings more than three decades of animal health experience to the role of executive director for the company. He is a graduate of the University of Missouri College of Veterinary Medicine and practiced veterinary medicine for 10 years. Boehringer Ingelheim Animal Health USA Inc. announced today the appointment of Dr. Scott King as the new executive director of the company’s U.S. cattle business. “Cattle producers and veterinarians put long hours and hard work into raising healthy herds, and I am excited to lead the team at Boehringer Ingelheim as we work hand-in-hand with them to prevent and manage conditions that can impact cattle health,” says King, executive director of the U.S. Cattle Business at Boehringer Ingelheim Animal Health USA Inc. “As a veterinarian, I know that prioritizing animal health and well-being is essential to producing wholesome beef and dairy products, and Boehringer Ingelheim is a key partner in this mission with our ‘cattle first’ philosophy.” King has served as director of marketing for the U.S. cattle business at Boehringer Ingelheim since 2015. He joined the company in 2014 as director of marketing for the company’s U.S. equine business and has held various marketing and technical leadership roles at […]

Click here to view original web page at www.bovinevetonline.com

DOVER, DE – Young Delaware companies in need of funding to help expand their business can now apply to compete for an Encouraging Development, Growth and Expansion (EDGE) grant from the Division of Small Business (DSB). The division will be accepting EDGE grant applications between now and March 31 from promising early-stage businesses throughout Delaware. Businesses that are less than seven years old and employ no more than 10 employees are eligible to apply for an EDGE grant. In previous rounds, businesses were required to be less than five years old, but DSB chose to expand this requirement to provide more small businesses with the opportunity to apply for funding. “We know that it may take a few years for some small businesses to get off the ground, especially the businesses in our STEM category,” said DSB Director Regina Mitchell. “By expanding the number of years that eligible EDGE grant applicants have been in business, we are hopeful that even more Delaware start-up companies will be able to take advantage of the opportunity to apply.” EDGE grants are awarded through a competitive selection process. Five STEM-based companies can receive up to $100,000 for eligible expenses while five Entrepreneur Class […]

Click here to view original web page at news.delaware.gov

Amazon’s cloud arm AWS launched AWS Lift in India to help small and midsize businesses (SMBs) with their digital transformation. Focused on businesses with annual revenues of 80 to 625 crore, AWS Lift program will offer access to 200 fully-featured services on AWS. These companies will be able to leverage AWS services without any associated costs. With a minimum billing fee of $1 and no lock-in periods, companies will be able to leverage the pay-as-you-go model to develop their operations and transform processes to drive new revenue growth. “Our SMB customers are already seeing business results by leveraging the cloud to enhance their productivity, increase customer acquisition, and expand into new markets. We look forward to empowering more customers to adopt the cloud with AWS Lift, in collaboration with our partner network, as India realizes the vision to become a digitally empowered society and knowledge economy,” said Puneet Chandok, president of commercial business, AWS India and South Asia. Notably, Amazon announced in 2020 that it will support digitalisation of 10 million SMBs in India by 2025. Last year, AWS launched SMB Vidyalaya to support the digital upskilling of small businesses and introduced Amazon Digital Suite for offering software solutions. […]

Click here to view original web page at www.techcircle.in

Mac McCullough, School of Public and Population Health School of Public and Population Health Associate Professor Mac McCullough recently co-published a report titled, “The Opportunity Cost of COVID for Public Health Practice: COVID-19 Pandemic Response Work and Lost Foundational Areas of Public Health Work” in the Journal of Public Health Management and Practice. McCullough’s research shines a light on the extent to which existing public health workers were pulled away from their usual work to contribute to the COVID-19 response, potentially leading to less work being done in other public health programs during the pandemic. All public health program areas contributed at least 20% of their workforce time to COVID-19 response, the report shows, meaning 20% less time devoted to their usual work, such as environmental health services, chronic disease prevention, and other essential public health services. The report concludes that there was a considerable public health “opportunity cost” to the public health systems’ large and prolonged COVID-19 response. Persistent understaffing in the public health system remains an important issue, according to the study. McCullough also co-wrote a blog post, which tackles important policy questions from the study, in JPHMP Direct . McCullough’s research involves examining investments in public […]

Click here to view original web page at www.boisestate.edu

CHARLOTTE – Name two distinct styles of investing…AND GO! Ding ding ding if the first thing that came to mind was growth and value investing, you win the prize! In this article we will discuss the meaning of both of these styles as well as if one is favored more during the market we are in. Let’s begin with growth. Growth companies tend to be those with revenues growing faster than their broader markets. They do not typically pay dividends and historically have been more volatile. Growth stocks are usually priced higher than the broader market because investors are willing to bet on their potential for continued earnings growth. In contrast, value stocks are generally considered less expensive compared to the broader market or their own intrinsic value. They tend to be more mature companies with less opportunity for earnings growth and compensate investors with dividend payments. As we move through a slowing growth environment, heightened volatility is expected to remain. Tilting the portfolio towards one style or another could benefit portfolios, but not having exposure to a style when the market turns could be detrimental to the long-term goals of a portfolio. How should you position your portfolio? […]

Click here to view original web page at www.minthilltimes.com

Iryna Drozd I covered Verve Therapeutics (NASDAQ: VERV ) in August 2021, when it was trading at its all-time highs. Now that it has dropped over 60%, it is time to check if this is a correction that creates an opportunity, or an exodus that should make one follow the fleet. Verve Therapeutics is a developer of gene therapies for cardiovascular diseases. It was co-founded by two well-known, highly regarded Indian origin scientists whose goal was to prevent heart attacks through once in a lifetime genetic treatments : …figure out what causes people to have premature heart attacks…a plan to discover what puts people at risk for heart attacks. Then … figure out which risk factors were actually important, before finding a way to intervene before health problems began. Verve’s goal was to find a drug whose beneficial effect on the heart: … could last, potentially, a lifetime. So far so good, and Verve did start out well with a big IPO, but it has gone down a lot from 2021. Lead asset VERVE-101 is designed to permanently turn off the PCSK9 gene in the liver, which disrupts blood PCSK9 protein production and thus reduces blood LDL-C levels. A […]

Click here to view original web page at seekingalpha.com

On February 28, 2023, the U.S. Department of Commerce (“Commerce”) released details on the application process for projects to construct, expand or modernize commercial facilities for the production of leading-edge, current-generation, and mature-node semiconductors. This includes both front-end wafer fabrication and back-end packaging (see CHIPS Incentives Program – Commercial Fabrication Facilities ). Awards will take the form of direct funding, federal loans, and/or federal guarantees of third-party loans. Commerce will be releasing separate Notices of Funding Opportunity (NOFO) for semiconductor materials and equipment facilities in the late spring, and one for research and development facilities in the fall. Direct funding for all three NOFOs is available in an amount up to $38.22 billion and up to $75 billion in direct loan or guaranteed principal amounts. Below is a detailed discussion of eligible projects, amount and types of funding, the application process and timing, evaluation criteria and restrictions for awardees. Notably, however, Commerce has left many important questions unanswered. Neither the NOFO nor the fact sheets provide guidance on the manufacturing clawback or the technology clawback. With regard to the manufacturing clawback, the NOFO simply states the following: Under the CHIPS Act, a successful applicant must enter into an agreement […]

Click here to view original web page at www.akingump.com